alpha-D-Glcp-(1->2)-[alpha-D-Glcp-(1->3)]-beta-D-Galp

Term ID

CHEBI:147944

Synonyms

(2R,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
alpha-D-gluco-hexopyranosyl-(1->2)-[alpha-D-gluco-hexopyranosyl-(1->3)]-beta-D-galacto-hexopyranose
alpha-D-glucopyranosyl-(1->2)-[alpha-D-glucopyranosyl-(1->3)]-beta-D-galactopyranose
Glc(a1-2)[Glc(a1-3)]b-Gal

Definition

A trisaccharide that is β-D-galactopyranose in which the hydroxy groups at positions 2 and 3 have each been converted into the corresponding α-D-glucopyranosyl derivative.

References

glygen:G18629CD
glytoucan:G18629CD

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Glcp-(1->2)-[alpha-D-Glcp-(1->3)]-beta-D-Galp

Phenotype where environments contain alpha-D-Glcp-(1->2)-[alpha-D-Glcp-(1->3)]-beta-D-Galp

Phenotype modified by environments containing alpha-D-Glcp-(1->2)-[alpha-D-Glcp-(1->3)]-beta-D-Galp

Phenotype affecting alpha-D-Glcp-(1->2)-[alpha-D-Glcp-(1->3)]-beta-D-Galp

Human Disease Model